The trial sites for the combination therapies are yet to be identified, but the institute hopes to collaborate with hospitals in four to five cities in India.(REUTERS)

IICT partners with Mylan for combination therapy trials

By Anonna Dutt | Hindustan Times, New Delhi, New Delhi
UPDATED ON SEP 23, 2020 11:51 PM IST
The institute had identified first three combination therapies, for Phase 3 clinical trials, based on computational modelling of molecules and laboratory-based data. Another five combinations are also in the works and will be finalised after preliminary data for the same is received.
Story Saved